Literature DB >> 26423426

Clinical and serologic features of primary Sjögren's syndrome concomitant with autoimmune hemolytic anemia: a large-scale cross-sectional study.

Wen Wen1, Yanying Liu1, Chuchu Zhao1, Xiaolin Sun1, Chunfang Zhang2, Zhanguo Li3.   

Abstract

Autoimmune hemolytic anemia (AIHA) is an uncommon but clinically significant disorder in primary Sjögren's syndrome (pSS). Among 565 pSS patients hospitalized in Peking University People's Hospital from January 2000 to March 2013, 16 patients were diagnosed with AIHA (2.8% prevalence). AIHA presented at the onset of pSS without overt sicca symptoms in 3 of the 16 patients. Primary biliary cirrhosis (PBC) was more prevalent in the patients with SS-AIHA than in those without (p = 0.007). Edema, fever, and liver involvement occurred significantly more frequently in pSS patients with AIHA than those without AIHA (p = 0.035, p = 0.029, p = 0.024, respectively). The pSS patients with AIHA were more vulnerable to leukopenia and thrombocytopenia than those without AIHA (p = 0.004 and p = 0.001, respectively). Additionally, the levels of complement component 3 (C3) and complement component 4 (C4) were significantly lower in the SS-AIHA group (p = 0.008 and p = 0.037, respectively). Taken together, our results indicate that pSS should be considered in the differential diagnosis of AIHA, even in the absence of sicca symptoms. Among pSS patients, the existence of PBC, cytopenia, or hypocomplementemia suggests a higher risk of suffering from AIHA.

Entities:  

Keywords:  Anemia; Autoimmunity; Cytopenia; Primary biliary cirrhosis; Sjögren’s syndrome

Mesh:

Substances:

Year:  2015        PMID: 26423426     DOI: 10.1007/s10067-015-3081-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  22 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  Clinical and immunological characteristics of elderly onset Sjögren's syndrome: a comparison with younger onset disease.

Authors:  M Tishler; I Yaron; I Shirazi; M Yaron
Journal:  J Rheumatol       Date:  2001-04       Impact factor: 4.666

3.  Autoimmune hemolytic anemia in an elderly patient with primary Sjögren's syndrome.

Authors:  Masayuki Kikawada; Daisuke Watanabe; Akihiro Kimura; Haruo Hanyu; Hiromi Serizawa; Toshihiko Iwamoto
Journal:  Intern Med       Date:  2005-12       Impact factor: 1.271

4.  [Exacerbation of autoimmune neutropenia to agranulocytosis in association with severe autoimmune thrombocytopenia and hemolytic anemia in a patient with Sjögren's syndrome].

Authors:  Sonoko Shimoji; Yohko Takiuchi; Hayato Maruoka; Daichi Inoue; Takaharu Kimura; Minako Mori; Yuya Nagai; Katuhiro Togami; Sumie Tabata; Masayuki Kurata; Akiko Matsushita; Kenichi Nagai; Takayuki Takahashi
Journal:  Rinsho Ketsueki       Date:  2011-07

5.  Features of Sjögren's syndrome in primary biliary cirrhosis.

Authors:  D Alarcón-Segovia; E Díaz-Jouanen; E Fishbein
Journal:  Ann Intern Med       Date:  1973-07       Impact factor: 25.391

6.  Autoimmune hemolytic anemia in patients with systemic lupus erythematosus.

Authors:  S I Kokori; J P Ioannidis; M Voulgarelis; A G Tzioufas; H M Moutsopoulos
Journal:  Am J Med       Date:  2000-02-15       Impact factor: 4.965

7.  Pathogenesis of Sjögren's syndrome: what we know and what we should learn.

Authors:  Athanasios G Tzioufas; Efstathia K Kapsogeorgou; Haralampos M Moutsopoulos
Journal:  J Autoimmun       Date:  2012-02-10       Impact factor: 7.094

8.  Primary Sjogren's syndrome and autoimmune hemolytic anemia in sisters. A family study.

Authors:  E P Boling; J Wen; J D Reveille; W B Bias; T M Chused; F C Arnett
Journal:  Am J Med       Date:  1983-06       Impact factor: 4.965

9.  Autoimmune hemolytic anemia preceding Sjögren's syndrome.

Authors:  A Schattner; M Shtalrid; A Berrebi
Journal:  J Rheumatol       Date:  1983-06       Impact factor: 4.666

10.  Primary Sjögren syndrome complicated by autoimmune hemolytic anemia and pure red cell aplasia.

Authors:  Stelios F Assimakopoulos; Sotiria Michalopoulou; Maria Melachrinou; Nikolaos Giannakoulas; Christos Papakonstantinou; Alexandra Lekkou; Charalambos Gogos
Journal:  Am J Med Sci       Date:  2007-12       Impact factor: 2.378

View more
  5 in total

1.  Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemia: A case report.

Authors:  Dan-Tong Zhao; Yan-Min Liu; Ying Han; Hai-Ping Zhang; Yan Zhao; Hui-Ping Yan
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

Review 2.  Diagnosis and Management of Autoimmune Hemolytic Anemia in Patients with Liver and Bowel Disorders.

Authors:  Cristiana Bianco; Elena Coluccio; Daniele Prati; Luca Valenti
Journal:  J Clin Med       Date:  2021-01-22       Impact factor: 4.241

3.  Iguratimod in treatment of primary Sjögren's syndrome concomitant with autoimmune hemolytic anemia: A case report.

Authors:  Juan Zhang; Xin Wang; Jing-Jing Tian; Rong Zhu; Rui-Xue Duo; Yi-Chen Huang; Hai-Li Shen
Journal:  World J Clin Cases       Date:  2022-02-06       Impact factor: 1.337

4.  Clinical and laboratory features of primary Sjögren's syndrome complicated with mild to severe thrombocytopenia.

Authors:  Jian Wu; Xin Chang; Jian Zhang; Cuiping Liu; Mingxing Liu; Weichang Chen
Journal:  Ann Transl Med       Date:  2022-03

5.  Comparative analysis of connective tissue disease-associated interstitial lung disease and interstitial pneumonia with autoimmune features.

Authors:  Mengxue Tian; Wenhan Huang; Feifeng Ren; Lei Luo; Jun Zhou; Dongmei Huang; Lin Tang
Journal:  Clin Rheumatol       Date:  2019-11-22       Impact factor: 2.980

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.